FLNA
Filana Therapeutics, Inc.
NASDAQ: FLNA · HEALTHCARE · BIOTECHNOLOGY
$1.44
-7.69% today
Updated 2026-04-29
Market cap
$77.78M
P/E ratio
—
P/S ratio
2.54x
EPS (TTM)
$-1.88
Dividend yield
—
52W range
$1 – $5
Volume
0.5M
Filana Therapeutics, Inc. (FLNA) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Operating cash flow | $-77.51M | $-82.03M | $-116.93M | $-32.25M |
| Capital expenditures | $2.71M | $414000.00 | $103000.00 | $581000.00 |
| Depreciation | — | — | — | — |
| Stock-based comp | $2.07M | $4.59M | $16.29M | $19.58M |
| Free cash flow | $-80.23M | $-82.44M | $-117.03M | $-32.83M |
| Investing cash flow | — | — | — | — |
| Financing cash flow | — | — | — | — |
| Dividends paid | — | — | — | — |
| Share repurchases | — | — | — | — |
| Debt repayment | — | — | — | — |
| Net change in cash | — | — | — | — |